The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 1 µg/ml. ab18450-Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
FunctionMay activate NF-kappa-B and promote apoptosis. May activate JNK and be involved in T-cell differentiation. Required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).
Tissue specificityHighly expressed in heart, brain, placenta, pancreas, lymph node, thymus and prostate. Detected at lower levels in lung, skeletal muscle, kidney, testis, uterus, small intestine, colon, spleen, bone marrow and fetal liver. Very low levels were found in adult liver and peripheral blood leukocytes.
Sequence similaritiesContains 1 death domain. Contains 4 TNFR-Cys repeats.
Tumor necrosis factor receptor superfamily member 21 antibody
Tumor necrosis factor receptor superfamily member 21 precursor antibody
Anti-DR6 antibody [Luke-1] images
Flow Cytometry - DR6 antibody [Luke-1] (ab17318)
Ab17318 at a concentration of 1 ug/ml used in mock transfecting (thin line) or transfecting (thick line) HEK 293T cells with an expression plasmid coding for the extracellular domain of human DR6 by Flow Cytometry.
References for Anti-DR6 antibody [Luke-1] (ab17318)
has not yet been referenced specifically in any publications.
Publishing research using ab17318? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"